Background: Ganciclovir-resistant cytomegalovirus (GR-CMV) is a serious complication of transplantation. Recurrence after primary infection is common. Little is known about CMV drug resistance and latency.
Objective: Review CMV genotype during episodes of recurrent CMV viremia after prior documentation of ganciclovir resistance to evaluate if resistance is redemonstrated.
Methods: All adult transplant recipients with history of GR-CMV viremia from January 1, 2011, to December 31, 2015, were screened; those with subsequent laboratory evidence of recurrent CMV viremia and genotyping were included.
Results: A total of 23 patients had genetically confirmed GR-CMV within the study time period; 14 were excluded due to lack of repeat resistance testing at recurrence and 4 due to of lack of negativity between testing, leaving 5 patients with 7 episodes of recurrent viremia to evaluate. At first recurrent viremia, 4 patients (80%) demonstrated resistant genotype; 1 patient had wild type. Two patients went on to have a second viremia recurrence; both demonstrated wild-type genotype, despite the fact that the first recurrence in these patients was resistant genotype.
Conclusion: In transplant recipients with history of GR-CMV, it appears that there is strain variability in latency: repeat genetic testing in patients with recurrent viremia after GR-CMV should be conducted. In the setting of wild-type repopulation, use of GCV should be considered.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1060028018760578 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Impact of Cytomegalovirus Infection on Ulcerative Colitis Relapse: A Multicenter Retrospective Cohort Study.
J Inflamm Res
November 2024
Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China.
Purpose: Cytomegalovirus (CMV) infection exacerbates intestinal inflammation in ulcerative colitis (UC) patients, yet the effect of CMV infection on UC relapse has not been fully elucidated. This study aimed to investigate the impact of CMV infection on UC relapse and identify associated risk factors.
Patients And Methods: This multicenter retrospective cohort study included UC patients who visited research centers from January 2016 to December 2020.
Dynamic Presentations of Recurrent Post-Transplant Lymphoproliferative Disorder in a Heart Transplant Recipient: A Rare Case Study.
ACG Case Rep J
November 2024
Division of Gastroenterology, Henry Ford Hospital, Detroit, MI.
Post-transplant lymphoproliferative disorders (PTLD) are complications that arise from post-transplantation immunosuppressive therapy. Although Epstein-Barr virus (EBV) viremia is often seen in PTLD, it is not a definitive feature for diagnosis. We report a rare case of recurrent PTLD in a 26-year-old heart transplant recipient on high-dose tacrolimus who presented with emesis, fatigue, and bloody diarrhea.
View Article and Find Full Text PDFCase report: Lichenoid esophagitis revealing an HIV infection.
Front Med (Lausanne)
October 2024
Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Esophageal lichen planus is an underrecognized manifestation of lichen planus. It is typically diagnosed based on characteristic endoscopic findings, such as hyperkeratosis, trachealization, denudation and/or stenosis, along with the presence of a lichenoid infiltrate in histopathological examination. In cases where no other manifestation of lichen planus are found and direct immunofluorescence for fibrinogen along the basement membrane is negative, the term "lichenoid esophagitis" should be preferred.
View Article and Find Full Text PDFEpidemiology and Outcomes of Recurrent Infection Among Hematopoietic Cell Transplant Recipients: A Single-center, Retrospective 10-year Study.
Open Forum Infect Dis
October 2024
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Article Synopsis
- * Among 3,479 HCT patients, 416 had an initial CDI, with a recurrence rate of 10% within 12 weeks; metronidazole monotherapy was linked to a higher risk of recurrence.
- * Results indicate that while only a small percentage required hospital admission after recurrence, no patients died within 30 days, highlighting the need for further research to understand the risk factors for recurrence and to improve treatment strategies.
Dynamic findings of brain magnetic resonance imaging in a haploidentical hematopoietic stem cell transplantation recipient with cytomegalovirus ventriculoencephalitis: a case report and systematic review.
Front Immunol
October 2024
Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Article Synopsis
- A case study was presented involving a 54-year-old man who developed cytomegalovirus (CMV) encephalitis after undergoing haploidentical donor hematopoietic stem cell transplantation (HID-HSCT) for acute lymphoblastic leukemia, showing unique brain MRI findings despite no initial neurological symptoms.
- *The patient experienced various complications, including severe graft-versus-host disease, recurrent CMV viremia, and worsening brain conditions, ultimately leading to a diagnosis of CMV encephalitis through advanced testing of cerebrospinal fluid.
- *Despite treatment with antiviral medications, the patient's condition deteriorated, resulting in death, highlighting the need for early diagnosis and innovative therapies, such as virus-specific immune treatments, for
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!